{"data":[{"accessionNo":"0001172661-26-003481","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001764013","issuerName":"IMMUNOVANT, INC.","ticker":"IMVT","cusip":"45258J102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":9341151,"percentOfClass":4.55,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"},{"accessionNo":"0001172661-26-003481","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001764013","issuerName":"IMMUNOVANT, INC.","ticker":"IMVT","cusip":"45258J102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":9341151,"percentOfClass":4.55,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"},{"accessionNo":"0001172661-26-003481","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001764013","issuerName":"IMMUNOVANT, INC.","ticker":"IMVT","cusip":"45258J102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":9341151,"percentOfClass":4.55,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"},{"accessionNo":"0001140361-25-045411","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001764013","issuerName":"Immunovant, Inc.","ticker":"IMVT","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-12","reportingPerson":"Roivant Sciences Ltd.","reportingCik":"0001635088","personType":"CO","sharesOwned":113327007,"percentOfClass":55.9,"filedAt":"2025-12-12","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"},{"accessionNo":"0000315066-25-002737","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001764013","issuerName":"IMMUNOVANT INC","ticker":"IMVT","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":14729554.78,"percentOfClass":8.4,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"},{"accessionNo":"0000315066-25-002737","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001764013","issuerName":"IMMUNOVANT INC","ticker":"IMVT","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":14729554.78,"percentOfClass":8.4,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/imvt"}],"updatedAt":"2026-11-04T03:05:43.501Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/imvt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}